A Multi-dose Study on the Safety and Efficacy of Self-administered Intranasal AD17002 Treatment for Eosinophilic Asthma
Clinical trial NCT07250594 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07250594
- Sponsor
- Advagene Biopharma Co. Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-01
- Primary completion
- 2026-10-01
- Enrollment
- 126
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.